Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macroph
about
Macrophage Heterogeneity and Plasticity: Impact of Macrophage Biomarkers on AtherosclerosisThe 5'-AMP-Activated Protein Kinase (AMPK) Is Involved in the Augmentation of Antioxidant Defenses in Cryopreserved Chicken SpermExenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages.Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.Protective Role of Grape Seed Proanthocyanidins Against Ccl4 Induced Acute Liver Injury in MiceRenoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the KidneyMetformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency.Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation.Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE/NFκB Pathway Suppression.Magnolia officinalis L. Fortified Gum Improves Resistance of Oral Epithelial Cells Against Inflammation.Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling.Recent novel approaches to limit oxidative stress and inflammation in diabetic complications.Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE.Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia.Metabolic Effects of Metformin in the Failing Heart
P2860
Q26780531-9F8BAC71-D427-414A-AA30-89E1D91ACE36Q28546852-16A260F2-9286-4EDE-B686-7F9307D86F96Q35956905-B48B8AA3-F8DE-4A86-85AC-FFFDBF9AA1B6Q36640261-EDA664DF-4C9C-4443-B6AE-D293DF3F1C99Q36710120-A6E3B828-B33C-4703-9D30-55BDCD26C976Q37366972-EC85BFC9-EC52-4B7E-9657-B0FF31BEB2C7Q38645850-CA684944-23A1-488A-8E84-5BF908EEEABBQ38673914-439BBA91-C0C5-4BEC-94E3-A1B5154EE91AQ40867355-43D3D4D4-4269-4D11-8836-7B048AD06CCCQ41430394-0E7598AA-656D-42E4-9DE8-8285F475F671Q46489519-0BD54D06-E062-4CEE-A46A-D123AA368097Q46515365-66503801-BE1F-482F-8366-35C00589AAB8Q54956778-752CADDA-E941-474D-95AA-45D32B90AA20Q55043209-3449CCBD-BABD-4798-864D-69EB9D1E8728Q55240540-26B4FE36-1FE4-48FA-A233-17A445E4DD6EQ59138235-A84389E4-15A5-43F5-ADA7-8074EF363DE6
P2860
Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macroph
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Metformin affects macrophages' ...... ulated human monocytes/macroph
@en
Metformin affects macrophages' ...... ulated human monocytes/macroph
@nl
type
label
Metformin affects macrophages' ...... ulated human monocytes/macroph
@en
Metformin affects macrophages' ...... ulated human monocytes/macroph
@nl
prefLabel
Metformin affects macrophages' ...... ulated human monocytes/macroph
@en
Metformin affects macrophages' ...... ulated human monocytes/macroph
@nl
P2093
P1476
Metformin affects macrophages' ...... ulated human monocytes/macroph
@en
P2093
Anna Duława-Bułdak
Dariusz Suchy
Krzysztof Łabuzek
Michał Kozłowski
Rafał Jakub Bułdak
Sebastian Liber
Łukasz Bułdak
P304
P356
10.1016/J.PHAREP.2013.11.008
P577
2014-04-13T00:00:00Z